| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 32.418 | 24.907 | 24.906 | 27.285 | 31.487 | 49.793 | 53.947 | 56.701 | 82.793 | 103.592 |
| Total Income - EUR | 32.418 | 24.907 | 24.907 | 27.285 | 31.487 | 49.793 | 53.947 | 56.701 | 82.793 | 103.592 |
| Total Expenses - EUR | 31.585 | 27.700 | 25.384 | 27.487 | 26.954 | 46.789 | 47.812 | 43.885 | 55.429 | 92.057 |
| Gross Profit/Loss - EUR | 833 | -2.792 | -477 | -201 | 4.533 | 3.004 | 6.135 | 12.816 | 27.364 | 11.535 |
| Net Profit/Loss - EUR | -140 | -3.041 | -4.398 | -474 | 4.218 | 2.506 | 5.596 | 12.249 | 26.537 | 8.428 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Adymedfam-Nt Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 44.718 | 39.915 | 38.163 | 36.455 | 35.749 | 33.132 | 31.449 | 30.595 | 29.554 | 28.446 |
| Current Assets | 9.341 | 19.022 | 15.559 | 18.632 | 18.272 | 18.227 | 4.665 | 9.326 | 30.640 | 14.905 |
| Inventories | 3.458 | 2.868 | 3.303 | 3.279 | 3.215 | 3.154 | 0 | 0 | 716 | 1.934 |
| Receivables | 1.307 | 2.803 | 11.984 | 15.417 | 15.118 | 13.909 | 3.967 | 4.596 | 6.559 | 5.629 |
| Cash | 4.576 | 13.352 | 272 | -63 | -62 | 1.164 | 699 | 4.730 | 23.366 | 7.342 |
| Shareholders Funds | 137 | -2.906 | -7.255 | -7.596 | -3.696 | -1.119 | 4.501 | 16.764 | 43.249 | 8.470 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 53.922 | 61.843 | 60.977 | 62.683 | 57.716 | 52.478 | 31.613 | 23.157 | 16.945 | 34.881 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Adymedfam-Nt Srl